Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Liver transplantation: an update 2007.

Said A, Einstein M, Lucey MR.

Curr Opin Gastroenterol. 2007 May;23(3):292-8. Review.

PMID:
17414845
2.

Liver transplantation: an update.

Said A, Lucey MR.

Curr Opin Gastroenterol. 2006 May;22(3):272-8. Review.

PMID:
16550042
3.

Liver transplantation.

Brown KA.

Curr Opin Gastroenterol. 2005 May;21(3):331-6. Review.

PMID:
15818154
4.

Liver transplantation: an update 2008.

Said A, Lucey MR.

Curr Opin Gastroenterol. 2008 May;24(3):339-45. doi: 10.1097/MOG.0b013e3282f8e27e. Review.

PMID:
18408462
5.

Liver transplantation: an update 2009.

Skagen C, Lucey M, Said A.

Curr Opin Gastroenterol. 2009 May;25(3):202-8. doi: 10.1097/MOG.0b013e3283299652. Review.

PMID:
19349862
6.

[Liver disease recurrence after liver transplantation].

Rakela B J.

Rev Med Chil. 2010 Apr;138(4):504-10. doi: /S0034-98872010000400017. Epub 2010 Jun 30. Spanish.

7.

Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.

de la Mata M, Cuende N, Huet J, Bernardos A, Ferrón JA, Santoyo J, Pascasio JM, Rodrigo J, Solórzano G, Martín-Vivaldi R, Alonso M.

Transplantation. 2006 Dec 15;82(11):1429-35.

PMID:
17164713
8.

Polysubstance abuse in liver transplant patients and its impact on survival outcome.

Nickels M, Jain A, Sharma R, Orloff M, Tsoulfas G, Kashyap R, Bozorgzadeh A.

Exp Clin Transplant. 2007 Dec;5(2):680-5.

9.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators..

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

10.

Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.

Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.

Dig Liver Dis. 2009 May;41(5):350-6. doi: 10.1016/j.dld.2008.09.018. Epub 2008 Nov 28.

PMID:
19046932
11.

Liver transplantation for hepatocellular carcinoma.

Heimbach JK.

Cancer J. 2008 Mar-Apr;14(2):95-9. doi: 10.1097/PPO.0b013e31816a0f6f.

PMID:
18391614
12.

The Bergamo Kidney Transplant Program.

Perico N, Cravedi P, Ruggenenti P, Gotti E, Rota G, Locatelli G, Gambara V, Perna A, Rota S, Remuzzi G.

Clin Transpl. 2005:85-100.

PMID:
17424727
13.

Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.

Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.

Transplant Proc. 2009 Apr;41(3):1041-3. doi: 10.1016/j.transproceed.2009.02.030.

PMID:
19376421
14.

Liver and intestine transplantation in the United States, 1997-2006.

Freeman RB Jr, Steffick DE, Guidinger MK, Farmer DG, Berg CL, Merion RM.

Am J Transplant. 2008 Apr;8(4 Pt 2):958-76. doi: 10.1111/j.1600-6143.2008.02174.x.

15.

Hepatitis C.

Burra P.

Semin Liver Dis. 2009 Feb;29(1):53-65. doi: 10.1055/s-0029-1192055. Epub 2009 Feb 23. Review.

PMID:
19235659
16.

Survival benefit after liver transplantation: a single European center experience.

Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD.

Transplantation. 2009 Sep 27;88(6):826-34. doi: 10.1097/TP.0b013e3181b26807.

PMID:
19920783
17.

Management of liver transplant recipients with recurrent hepatitis C.

McCashland TM.

Curr Opin Organ Transplant. 2009 Jun;14(3):221-4. doi: 10.1097/MOT.0b013e32832ade76. Review.

PMID:
19444107
18.

Post-liver transplant cholestatic hepatitis C: a systematic review of clinical and pathological findings and application of consensus criteria.

Narang TK, Ahrens W, Russo MW.

Liver Transpl. 2010 Nov;16(11):1228-35. doi: 10.1002/lt.22175. Review.

19.

Hepatitis C therapy before and after liver transplantation.

Terrault NA.

Liver Transpl. 2008 Oct;14 Suppl 2:S58-66. doi: 10.1002/lt.21624. Review.

20.

Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection.

Carbone J, Micheloud D, Salcedo M, Rincon D, Bañares R, Clemente G, Jensen J, Sarmiento E, Rodriguez-Molina J, Fernandez-Cruz E.

Transpl Infect Dis. 2008 Dec;10(6):396-402. doi: 10.1111/j.1399-3062.2008.00329.x. Epub 2008 Jul 24.

PMID:
18657086

Supplemental Content

Support Center